A notable advancement in diabetes treatment is emerging with the introduction of tirzepatide at a dosage of 45mg. This new offering builds upon the existing success of tirzepatide, a dual GIP and GLP-1 target, and https://bookmarkprobe.com/story21584379/revolutionary-approach-tirzepatide-dose-for-glucose-control